San Francisco-based private equity firm Genstar Capital LLC has completed its $797 milion acquisition of PRA International, a global clinical research organization based in North Carolina, the company announced today.
Shareholders approved the acquisition Wednesday and will receive $30.50 per share of common stock in cash. PRA stock will be delisted from Nasdaq at the close of the  markets.
Elected BART leaders are considering banning panhandling and busking — playing music… Continue reading
Independent expert concludes manner of death was natural
Classes started Monday at George Washington High School, but the fallout of… Continue reading
Debate over power broker’s legacy exposes deep rifts in Chinese community
The City is preparing to close dozens of permanent, residential treatment beds… Continue reading
